1
Clinical Trials associated with BEBT-507 / Not yet recruitingPhase 1 BEBT-507在真性红细胞增多症患者中的多中心、开放性Ⅰ期临床试验
[Translation] A multicenter, open-label phase I clinical trial of BEBT-507 in patients with polycythemia vera
Ⅰa期临床研究
主要目的:评价BEBT-507在真性红细胞增多症(PV)患者的安全性和耐受性;
次要目的:评价BEBT-507在真性红细胞增多症(PV)患者中的有效性;评价BEBT-507药代动力学(PK)和药效动力学(PD)特征;为BEBT-507在真性红细胞增多症(PV)患者中的Ⅰb期临床试验提供推荐剂量。
Ⅰb期临床研究
主要目的:评价BEBT-507在真性红细胞增多症(PV)患者中的有效性;
次要目的:评价BEBT-507在真性红细胞增多症(PV)患者中安全性和耐受性;评价BEBT-507药代动力学(PK)特征;为BEBT-507在真性红细胞增多症(PV)患者中的Ⅲ期临床试验提供推荐剂量。
[Translation] Phase Ia clinical study
Main purpose: To evaluate the safety and tolerability of BEBT-507 in patients with polycythemia vera (PV);
Secondary purpose: To evaluate the efficacy of BEBT-507 in patients with polycythemia vera (PV); To evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of BEBT-507; To provide a recommended dose for the Phase Ib clinical trial of BEBT-507 in patients with polycythemia vera (PV).
Phase Ib clinical study
Main purpose: To evaluate the efficacy of BEBT-507 in patients with polycythemia vera (PV);
Secondary purpose: To evaluate the safety and tolerability of BEBT-507 in patients with polycythemia vera (PV); To evaluate the pharmacokinetic (PK) characteristics of BEBT-507; To provide a recommended dose for the Phase III clinical trial of BEBT-507 in patients with polycythemia vera (PV).
100 Clinical Results associated with BEBT-507
100 Translational Medicine associated with BEBT-507
100 Patents (Medical) associated with BEBT-507
100 Deals associated with BEBT-507